Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin

Infection and Immunity

Volumn 64, Issue 8, 1996, Pages 3168-3173

  Anderson, Richard ^a   Gao, Xiao Ming ^a   Papakonstantinopoulou, Anastasia ^a   Roberts, Mark ^b   Dougan, Gordon ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NEUROTOXIN; NEUTRALIZING ANTIBODY; TETANUS TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLOSTRIDIUM TETANI; CONTROLLED STUDY; GENE EXPRESSION; HUMAN CYTOMEGALOVIRUS; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SACCHAROMYCES CEREVISIAE; TETANUS;

EID: 0030036897     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.8.3168-3173.1996     Document Type: Article

References (50)

1. Barry, M. A., W. C. Lai, and S. A. Johnston. 1995. Protection against Mycoplasma pulmonis infection using expression-library immunisation. Nature (London) 377:632-635.
2. Charles, I. G., B. C. Rodgers, A. J. Makoff, S. N. Chatfield, D. E. Slater, and N. F. Fairweather. 1991. Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system. Infect. Immun. 59:1627-1632.
3. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/ Technology 10:888-892.
4. Chatfield, S. N., N. Fairweather, L. Charles, D. Pickard, M. Levine, D. Hone, M. Posada, R. A. Strugnell, and G. Dougan. 1992. Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine. Vaccine 10:53-60.
5. Cheng, L., P. R. Zeigelhoffer, and N. S. Yang. 1993. In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. USA 90:4455-4459.
6. Clare, J. J., F. B. Rayment, S. P. Ballentine, K. Sreekrishna, and M. A. Romanes. 1991. High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene. Bio/ Technology 9:455-460.
7. Conry, R. M., A. F. LoBuglio, J. Kantor, J. Schlom, F. Loechel, S. E. Moore, L. A. Sumerel, D. L. Barlow, S. Abrams, and D. T. Curiel. 1994. Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res. 54:1164-1168.
8. Conry, R. M., A. F. LoBuglio, F. Loechel, S. E. Moore, L. A. Sumerel, D. L. Barlow, and D. T. Curiel. 1995. A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther. 2:59-65.
9. Cox, G. J., T. J. Zamb, and L. A. Babiuk. 1993. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67:5664-5667.
10. Danko, I., J. D. Fritz, S. Jiao, K. Hogan, J. S. Latendresse, and J. A. Wolf. 1994. Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther. 1:114-121.
11. Davis, H. L., M. L. Michel, and R. G. Whalen. 1993. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2:1847-1851.
12. Davis, H. L., R. Schirmbeck, J. Reimann, and R. G. Whalen. 1995. DNA-mediated immunisation in mice induces a potent MHC class 1-restricted cytotoxic lymphocyte response to the hepatitis B envelope protein. Hum. Gene Ther. 6:1447-1456.
13. Davis, R. W., D. Botstein, and J. R. Roth. 1980. Advanced bacterial genetics, a manual for genetic engineering. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
14. Donnelly, J. J., A. Friedman, D. Martinez, D. L. Montgomery, J. W. Shiver, S. L. Motzel, J. B. Ulmer, and M. A. Liu. 1995. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in in- fluenza virus. Nat. Med. 1:583-587.
15. Fairweather, N. F., V. A. Lyness, and D. J. Maskell. 1987. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli. Infect. Immun. 55:2541-2545.
16. Figueiredo, D., C. Turcotte, G. Frankel, Y. Li, O. Dolly, G. Wilkin, D. Marriott, N. Fairweather, and G. Dougan. 1995. Characterization of recombinant tetanus toxin derivatives suitable for vaccine development. Infect. Immun. 63:3218-3221.
17. Fuller, D. H., and J. R. Haynes. 1994. A qualitative progression in HIV type 1 glycoprolein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. Hum. Retroviruses 10:1433-41.
18. Fynan, E. F., H. L. Robinson, and R. G. Webster. 1993. Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol. 12:785-789.
19. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1993. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90: 11478-11482.
20. Halpern, J. L., and A. Loftus. 1993. Characterisation of the receptor binding domain of tetanus toxin. J. Biol. Chem. 268:11188-11192.
21. Melting, T. B., O. Zwisler, and H. Weigandt. 1977. Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments. J. Biol. Chem. 252:187-193.
22. Helting, T. B., O. Zwisler, and H. Weigandt. 1977. Structure of tetanus toxin. II. Toxin binding to ganglioside. J. Biol. Chem. 252:194-197.
23. Justewicz, D. M., M. J. Morin, H. L. Robinson, and R. G. Webster. 1995. Antibody-forming cell response to virus challenge in mice with DNA encoding the influenza virus hemagglutinin. J. Virol. 69:7712-7717.
24. Lagging, L. M., K. Meyer, D. Hoft, M. Houghton, R. R. Belshe, and R. Ray. 1995. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69:5859-5863.
25. Li, Y., P. Foran, N. F. Fairweather, A. de Pavia, U. Weller, G. Dougan, and J. O. Dolly. 1994. A single mutation in the recombinant light chain of tetanus toxin abolishes its proteolytic activity and removes the toxicity seen after reconstitution with native heavy chain. Biochemistry 33:7014-7020.
26. Lowrie, D. B., R. E. Tascon, M. J. Colston, and C. L. Silva. 1994. Towards a DNA vaccine against tuberculosis. Vaccine 12:1537-1540.
27. Lu, S., J. C. Santoro, D. H. Fuller, J. R. Haynes, and H. L. Robinson. 1995. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 209:147-154.
28. Makoff, A. J., S. P. Ballantine, A. E. Smallwood, and N. F. Fairweather. 1989. Expression of tetanus toxin fragment C in E. coli: its purification and potential use as a vaccine. Biotechnology 7:1043-1046.
29. Manickan, E., R. J. Rouse, Z. Yu, W. S. Wire, and B. T. Rouse. 1995. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J. Immunol. 155:259-265.
30. Mor, G., D. M. Klinamn, S. Shapiro, E. Haglwara, M. Sedegah, J. A. Norman, S. L. Hoffman, and A. D. Steinberg. 1995. Complexity of the cytokine and antibody response elicited by immunising mice with Plasmodium yoelii circumsporozitc protein plasmid DNA. J. Immunol. 155:2039-2046.
31. Morris, N. P., E. Consiglio, L. D. Kohn, W. H. Habig, M. C. Hardegree, and T. B. Helting. 1980. Interaction of fragments B and C or tetanus toxin with neural and thyroid membranes and with gangliosides. J. Biol. Chem. 255: 6071-6076.
32. Niemann, H. 1991. Molecular biology of clostridial neurotoxins, p. 303-348. In J. Alouf and J. Freer (ed.), Sourcebook of bacterial protein toxins. Academic Press, London.
33. Raz, E., A. Watanabe, S. M. Baird, R. A. Eisenberg, T. B. Parr, M. Lotz, T. J. Kipps, and D. A. Carson. 1993. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. USA 90:4523-4527.
34. Romanos, M. A., A. J. Makoff, N. F. Fairweather, K. M. Beesley, D. E. Slater, F. B. Rayment, M. M. Payne, and J. J. Clare. 1991. Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA. Nucleic Acids Res. 19:1461-1467.
35. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1987. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
36. Schiavo, G., G. Ferrari, O. Rossetto, and C. Montecucco. 1991. Tetanus toxin receptor. Specific cross-linking of tetanus toxin to a protein of NGF-differentiated PC 12 cells. FEBS Lett. 290:227-230.
37. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866-9870.
38. Tang, D. C., M. DeVit, and S. A. Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature (London) 356:152-154.
39. Tite, J. P., X. M. Gao, M. Jenkins, M. Lipscombe, D. O'Callaghan, G. Dougan, and F. Y. Liew. 1990. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleopro- tein to the immune system using attenuated Salmonella typhimurium as a live carrier. Immunology 70:540-547.
40. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
41. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, and A. Friedman, et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
42. Wang, B., K. E. Ugen, V. Srikantan, M. G. Agadjanyan, K. Dang, Y. Refaeli, A. I. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156-4160.
43. Webster, R. G., E. F. Fynan, J. C. Santoro, and H. Robinson. 1994. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 12:1495-1498.
44. Wolff, J. A., J. J. Ludtke, G. Acsadi, P. Williams, and A. Jani. 1992. Longterm persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1:363-369.
45. Wolff, J. A., P. Williams, G. Acsadi, S. Jiao, A. Jani, and W. Chong. 1991. Conditions affecting direct gene transfer into rodent muscle in vivo. Bio-Techniques 11:474-485.
46. Xiang, Z. Q., S. Spitalnik, M. Tran, W. H. Wunner, J. Cheng, and H. C. Ertl. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199: 132-140.
47. Xiang, Z. Q., S. L. Spitalnik, J. Cheng, J. Erikson, B. Wojczyk, and H. C. Ertl. 1995. Immune responses to nucleic acid vaccines to rabies virus. Virology 209:569-579.
48. Xu, D., and F. Y. Liew. 1995. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein of L. major. Immunology 84: 173-176.
49. Yang, W., G. J. Waine, and D. P. McManus. 1995. Antibodies to Schistosoma japonicum (Asian bloodfluke) paramyosin induced by nucleic acid vaccination. Biochem. Biophys. Res. Commun. 212:1029-1039.
50. Zarozinski, C. C., E. F. Fynan, L. K. Selin, H. L. Robinson, and R. M. Welsh. 1995. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154:4010-4017.